Surprisingly, the knockdown of DDR1 further augmented the tumor cell immunogenicity induced by CIR, accompanied by increased intratumoral CD8 + T cell infiltration, Granzyme B and IFN-γ production, indicating an enhancement in the killing capacity of immune cells. The gene discussed is GZMB; the disease is neoplasm.